Monday, April 28, 2025

Why Wolfspeed Rocketed 27% Higher (Again) on Monday


Shares of silicon carbide chipmaker Wolfspeed surged 26.9% on Monday, continuing a rally following cautious optimism about recovering end markets as earnings season begins, despite no specific news before their May 8 earnings report. With a high short interest of 41%, many short sellers may have closed positions, contributing to a “short squeeze.” However, despite recent gains, Wolfspeed remains heavily indebted, faces uncertainty with a new CEO starting May 1, and is at risk of not receiving promised CHIPS Act funding, making other automotive chip stocks less risky options for investors.

Full Article

Related Posts

Up 40% in 2025: Is It Too Late to Buy Palantir Stock?

Palantir (PLTR) has defied the trend of declining tech stocks, rallying over 40% year-to-date amidst a challenging market influenced by tariffs and trade wars. The company, known for its data analytics platforms Gotham and Foundry, has experienced growth despite a slowdown in revenue increase, turning profitable in 2023 and achieving a 29% revenue boost in 2024, bolstered by its U.S. commercial business and AI tools. However, high valuations and potential impacts from government spending cuts...

Read more

Trump's first 100 days had the worst market performance in half a century

The current stock market performance is reminiscent of the challenging times during 1973 and 1974, particularly associated with President Richard Nixon's resignation and the subsequent presidency of Gerald Ford. These two leaders represent the only U.S. presidents in the post-World War II era who faced worse stock market conditions within their first 100 days in office. This comparison highlights the severity of the current economic situation and its historical parallels. Full Article

Read more

Tesla's "Moment of Truth"

In this podcast, Motley Fool analyst Sanmeet Deo and host Mary Long discuss Tesla's disappointing automotive segment results, questioning whether Elon Musk's increased focus on the company can improve performance. They highlight a significant decline in operating margins, lower vehicle deliveries, and rising R&D expenses, despite stronger results in energy and storage. Additionally, analyst Asit Sharma joins to compare AMD with its biggest competitor, while the podcast encourages listeners to explore full episodes and a...

Read more

Want to Avoid the "Magnificent Seven" and Generate Passive Income? This Vanguard ETF May Be for You

The "Magnificent Seven" stocks—Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla—experienced significant gains in 2023 and 2024 but are now underperforming the S&P 500 in 2025, with Microsoft down 8.1% and Tesla over 35%. Investors seeking alternatives might consider the Vanguard High Dividend Yield ETF, which offers exposure to industry-leading companies across non-tech sectors, achieving a 2.9% dividend yield and a balanced sector allocation. This ETF, with a low expense ratio of 0.06%, is...

Read more

Think Progressive Stock Is Expensive? This Chart Might Change Your Mind.

SummaryInvestors are increasingly interested in Progressive (PGR), driven by positive first-quarter earnings, despite its higher valuation compared to peers like Allstate and Chubb. The company has excelled in raising its revenue through effective marketing and innovative strategies, such as the launch of Cargo Plus for truck coverage, while facing challenges in a competitive auto insurance market. Despite potential risks from consumer backlash over rate increases, Progressive's strong operational performance justifies its premium valuations. Full Article

Read more

Nano-X Imaging (NNOX) Q4 2024 Earnings Call Transcript

Nano-X Imaging (NNOX) held its Q4 2024 earnings call on March 31, 2025, featuring CEO Erez Meltzer and CFO Ran Daniel. The company reported significant regulatory achievements, including FDA general use clearance in December and CE Mark designation for Nanox.ARC in February 2025. Meltzer highlighted advancements in market deployment, positive customer feedback, new channel partnerships, and efforts to penetrate the European market, along with updates on their Nanox.AI team and ongoing clinical trials to support...

Read more

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.